ConductScience.org, home

Paper39596381

Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.

Liu H and 9 others. Int J Mol Sci, 2024. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro. Papers, record 39596381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596381

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.25, provisional
iCite
Revised in PubMed
2026-03-09
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu HHongshuai
2McCollum AAinsley
3Krishnaprakash AAsvini
4Ouyang YYuxiao
5Shi TTianze
6Ratovitski TTamarahttps://orcid.org/0000-0003-4020-5644
7Jiang MMali
8Duan WWenzhen
9Ross CAChristopher A
10Jin JJinghttps://orcid.org/0000-0003-1508-8036

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RoscovitineMajor topic
Huntingtin ProteinMajor topic
NeuronsMajor topic
Cyclin-Dependent Kinase 5Major topic
Phosphorylation
Animals
Mice
Humans
Huntington Disease
Protein Kinase Inhibitors
Protein Processing, Post-Translational
CDC2 Protein Kinase

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 NS124084NINDS NIH HHSUnited StatesR01NS124084PubMedNIH RePORTER
R01 NS086452NINDS NIH HHSUnited StatesR01NS086452PubMedNIH RePORTER
R21 NS135139NINDS NIH HHSUnited StatesR21NS135139PubMedNIH RePORTER
R01NS086452NIH HHSUnited StatesR01NS086452PubMedNIH RePORTER
R21 NS125063NINDS NIH HHSUnited StatesR21NS125063PubMedNIH RePORTER
R21 NS125063NIH HHSUnited StatesR21NS125063PubMedNIH RePORTER

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,981,925R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy.iScience2020https://conductscience.org/library/papers/31981925PubMed
217,173,700Multiple pathways contribute to the pathogenesis of Huntington disease.Mol Neurodegener2006https://conductscience.org/library/papers/17173700PubMed
331,189,016Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model.Hum Mol Genet2019https://conductscience.org/library/papers/31189016PubMed
421,163,446Huntington's disease: from molecular pathogenesis to clinical treatment.Lancet Neurol2011https://conductscience.org/library/papers/21163446PubMed
530,185,623N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting.J Biol Chem2018https://conductscience.org/library/papers/30185623PubMed
624,353,748Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons.J Huntingtons Dis2012https://conductscience.org/library/papers/24353748PubMed
725,938,685The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model.Chronobiol Int2015https://conductscience.org/library/papers/25938685PubMed
821,044,075Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.J Neurochem2010https://conductscience.org/library/papers/21044075PubMed
934,888,656Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.Hum Mol Genet2022https://conductscience.org/library/papers/34888656PubMed
1027,693,427ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation.Stem Cell Reports2016https://conductscience.org/library/papers/27693427PubMed
1111,978,846Cyclin-dependent kinase 5 is required for associative learning.J Neurosci2002https://conductscience.org/library/papers/11978846PubMed
1217,160,145The role of CDK5/P25 formation/inhibition in neurodegeneration.Drug News Perspect2006https://conductscience.org/library/papers/17160145PubMed
1332,796,930Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.Nat Rev Neurol2020https://conductscience.org/library/papers/32796930PubMed
1431,296,921Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.J Hum Genet2019https://conductscience.org/library/papers/31296921PubMed
1517,209,049AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro.J Biol Chem2007https://conductscience.org/library/papers/17209049PubMed
1622,580,459Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis.Cell Cycle2012https://conductscience.org/library/papers/22580459PubMed
1726,002,103CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death.Hum Mol Genet2015https://conductscience.org/library/papers/26002103PubMed
1815,854,805Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat.Eur J Pharm Sci2005https://conductscience.org/library/papers/15854805PubMed
1932,452,382Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin.Elife2020https://conductscience.org/library/papers/32452382PubMed
2028,653,853Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.J Proteome Res2017https://conductscience.org/library/papers/28653853PubMed

See all 88 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41,850,723Huntingtin (HTT) interactome in regulation of DNA repair/remodeling and RNA processing pathways.Life Sci Alliance2026https://conductscience.org/library/papers/41850723PubMed
40,734,978Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease.Front Cardiovasc Med2025https://conductscience.org/library/papers/40734978PubMed
39,836,243CDK5: Insights into its roles in diseases.Mol Biol Rep2025https://conductscience.org/library/papers/39836243PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39596381

GET https://conductscience.org/api/papers/v1/39596381/references?page=2